BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9795385)

  • 1. Efficient induction of protective anti-malaria immunity by recombinant adenovirus.
    Rodrigues EG; Zavala F; Nussenzweig RS; Wilson JM; Tsuji M
    Vaccine; 1998 Nov; 16(19):1812-7. PubMed ID: 9795385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.
    Rodrigues EG; Zavala F; Eichinger D; Wilson JM; Tsuji M
    J Immunol; 1997 Feb; 158(3):1268-74. PubMed ID: 9013969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus.
    Rodrigues EG; Claassen J; Lee S; Wilson JM; Nussenzweig RS; Tsuji M
    Parasite Immunol; 2000 Mar; 22(3):157-60. PubMed ID: 10672197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
    Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
    González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
    J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites.
    Mishra S; Rai U; Shiratsuchi T; Li X; Vanloubbeeck Y; Cohen J; Nussenzweig RS; Winzeler EA; Tsuji M; Nussenzweig V
    Vaccine; 2011 Oct; 29(43):7335-42. PubMed ID: 21807053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
    Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
    Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.
    Bruna-Romero O; Rocha CD; Tsuji M; Gazzinelli RT
    Vaccine; 2004 Sep; 22(27-28):3575-84. PubMed ID: 15315836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complexity of protective immunity against liver-stage malaria.
    Doolan DL; Hoffman SL
    J Immunol; 2000 Aug; 165(3):1453-62. PubMed ID: 10903750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of Plasmodium.
    Rodríguez D; González-Aseguinolaza G; Rodríguez JR; Vijayan A; Gherardi M; Rueda P; Casal JI; Esteban M
    PLoS One; 2012; 7(4):e34445. PubMed ID: 22529915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.
    Fonseca JA; Cabrera-Mora M; Kashentseva EA; Villegas JP; Fernandez A; Van Pelt A; Dmitriev IP; Curiel DT; Moreno A
    PLoS One; 2016; 11(4):e0154819. PubMed ID: 27128437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dendritic cell-specific chemokine, dendritic cell-derived CC chemokine 1, enhances protective cell-mediated immunity to murine malaria.
    Bruna-Romero O; Schmieg J; Del Val M; Buschle M; Tsuji M
    J Immunol; 2003 Mar; 170(6):3195-203. PubMed ID: 12626578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.
    Sedegah M; Jones TR; Kaur M; Hedstrom R; Hobart P; Tine JA; Hoffman SL
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7648-53. PubMed ID: 9636204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.